Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cirrhotic cardiomyopathy is the term used to describe a constellation of features indicative of abnormal heart structure and function in patients with cirrhosis. These include systolic and diastolic dysfunction, electrophysiological changes, and macroscopic and microscopic structural changes.
Biomarker and diagnostic research for cirrhotic cardiomyopathy has been reported in the published literature.
5 clinical trials registered, 3 recruiting. Interventions under study include other interventions, drug therapy, and medical devices. Pipeline includes 1 PHASE4, 2 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07286643](https://clinicaltrials.gov/study/NCT07286643) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:46 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about cirrhotic cardiomyopathy
Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis
NA |
Post Graduate Institute of Medical Education and Research, Chandigarh |
RECRUITING |
[NCT07322237](https://clinicaltrials.gov/study/NCT07322237) | DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis | PHASE4 | Post Graduate Institute of Medical Education and Research, Chandigarh | RECRUITING |
[NCT06095466](https://clinicaltrials.gov/study/NCT06095466) | Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology | — | Post Graduate Institute of Medical Education and Research, Chandigarh | RECRUITING |
[NCT07502196](https://clinicaltrials.gov/study/NCT07502196) | Heart Problems in Children With Chronic Liver Disease | — | Assiut University | UNKNOWN |
[NCT06431919](https://clinicaltrials.gov/study/NCT06431919) | Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival | NA | Post Graduate Institute of Medical Education and Research, Chandigarh | UNKNOWN |
109 publications have been identified in PubMed for cirrhotic cardiomyopathy. Research spans Review / Meta-Analysis (30%), Clinical Trial Publication (24%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 33 | 30% |
Clinical study results | 26 | 24% |
Laboratory research | 17 | 16% |
Disease patterns and progression | 11 | 10% |
Testing and diagnosis research | 10 | 9% |
Other research | 9 | 8% |
New treatment approaches | 2 | 2% |
Patient case studies | 1 | 1% |
Alexander EC (2026). [PMID: 41711944](https://pubmed.ncbi.nlm.nih.gov/41711944/). *Pediatric nephrology (Berlin, Germany)*. [Basic Science / Preclinical]
Xu M (2026). [PMID: 41609991](https://pubmed.ncbi.nlm.nih.gov/41609991/). *Hepatology international*. [Review / Meta-Analysis]
Radu T (2026). [PMID: 41977091](https://pubmed.ncbi.nlm.nih.gov/41977091/). *J Clin Med*. [Epidemiology / Natural History]
Coevoet D (2026). [PMID: 41745633](https://pubmed.ncbi.nlm.nih.gov/41745633/). *Acta Gastroenterol Belg*. [Diagnostic / Biomarker]
Yang X (2026). [PMID: 41521148](https://pubmed.ncbi.nlm.nih.gov/41521148/). *The Journal of international medical research*. [Other]
Lamba M (2026). [PMID: 41722065](https://pubmed.ncbi.nlm.nih.gov/41722065/). *Ann Afr Med*. [Epidemiology / Natural History]
Miarka M (2026). [PMID: 42083488](https://pubmed.ncbi.nlm.nih.gov/42083488/). *Adv Clin Exp Med*. [Epidemiology / Natural History]
Lyssy LA (2026). [PMID: 32310549](https://pubmed.ncbi.nlm.nih.gov/32310549/). *Unknown Journal*. [Review / Meta-Analysis]
Gill M (2026). [PMID: 41247366](https://pubmed.ncbi.nlm.nih.gov/41247366/). *Transplantation*. [Basic Science / Preclinical]
Sumbal R (2026). [PMID: 42111395](https://pubmed.ncbi.nlm.nih.gov/42111395/). *J Clin Exp Hepatol*. [Review / Meta-Analysis]